CVS Health Corp (NYSE:CVS) Shares Bought by Davidson Investment Advisors

Davidson Investment Advisors grew its holdings in shares of CVS Health Corp (NYSE:CVS) by 1.3% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 234,116 shares of the pharmacy operator’s stock after purchasing an additional 2,930 shares during the period. CVS Health accounts for 1.5% of Davidson Investment Advisors’ portfolio, making the stock its 22nd biggest position. Davidson Investment Advisors’ holdings in CVS Health were worth $14,766,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the business. Baldwin Brothers Inc. MA grew its position in CVS Health by 1.1% in the 3rd quarter. Baldwin Brothers Inc. MA now owns 14,911 shares of the pharmacy operator’s stock valued at $941,000 after buying an additional 165 shares in the last quarter. Mutual Advisors LLC grew its position in CVS Health by 0.8% in the 2nd quarter. Mutual Advisors LLC now owns 20,641 shares of the pharmacy operator’s stock valued at $1,125,000 after buying an additional 172 shares in the last quarter. Enterprise Financial Services Corp grew its position in CVS Health by 3.7% in the 3rd quarter. Enterprise Financial Services Corp now owns 5,156 shares of the pharmacy operator’s stock valued at $325,000 after buying an additional 185 shares in the last quarter. Fiduciary Group LLC grew its position in CVS Health by 3.2% in the 2nd quarter. Fiduciary Group LLC now owns 6,485 shares of the pharmacy operator’s stock valued at $353,000 after buying an additional 200 shares in the last quarter. Finally, Legacy Advisors LLC grew its position in CVS Health by 2.5% in the 3rd quarter. Legacy Advisors LLC now owns 8,048 shares of the pharmacy operator’s stock valued at $508,000 after buying an additional 200 shares in the last quarter. 75.92% of the stock is currently owned by institutional investors.

Shares of NYSE:CVS traded up $0.31 during trading hours on Tuesday, hitting $72.04. 44,354 shares of the company’s stock traded hands, compared to its average volume of 8,219,084. CVS Health Corp has a 52 week low of $51.72 and a 52 week high of $82.15. The company has a debt-to-equity ratio of 1.32, a quick ratio of 0.61 and a current ratio of 0.92. The company’s fifty day simple moving average is $64.99 and its two-hundred day simple moving average is $58.74. The company has a market cap of $94.28 billion, a price-to-earnings ratio of 10.16, a price-to-earnings-growth ratio of 1.57 and a beta of 0.86.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.84 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.77 by $0.07. CVS Health had a net margin of 1.83% and a return on equity of 15.45%. The company had revenue of $64.81 billion during the quarter, compared to analyst estimates of $62.99 billion. During the same quarter last year, the firm posted $1.73 EPS. The business’s revenue for the quarter was up 36.5% on a year-over-year basis. On average, analysts anticipate that CVS Health Corp will post 7.01 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Monday, November 4th. Shareholders of record on Thursday, October 24th were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.78%. The ex-dividend date of this dividend was Wednesday, October 23rd. CVS Health’s dividend payout ratio is presently 28.25%.

In other CVS Health news, CFO Eva C. Boratto sold 8,130 shares of the company’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $65.00, for a total transaction of $528,450.00. Following the completion of the sale, the chief financial officer now directly owns 55,273 shares of the company’s stock, valued at $3,592,745. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Troyen A. Brennan sold 23,604 shares of the company’s stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $68.00, for a total transaction of $1,605,072.00. Following the sale, the executive vice president now directly owns 107,921 shares of the company’s stock, valued at $7,338,628. The disclosure for this sale can be found here. Insiders have sold 49,437 shares of company stock valued at $3,248,811 over the last ninety days. Insiders own 0.53% of the company’s stock.

A number of brokerages recently issued reports on CVS. Cowen set a $76.00 target price on shares of CVS Health and gave the company a “buy” rating in a research report on Monday, October 21st. Deutsche Bank began coverage on shares of CVS Health in a research report on Thursday, September 12th. They issued a “buy” rating and a $91.00 target price for the company. TheStreet upgraded shares of CVS Health from a “c+” rating to a “b-” rating in a research report on Monday, September 9th. SunTrust Banks increased their target price on shares of CVS Health to $85.00 and gave the company a “buy” rating in a research report on Thursday, November 7th. Finally, Raymond James increased their target price on shares of CVS Health from $75.00 to $80.00 and gave the company a “strong-buy” rating in a research report on Thursday, November 7th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $77.59.

CVS Health Company Profile

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

See Also: What is a dividend reinvestment plan?

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.